The German government presented a combined parliamentary report on agricultural biotechnology patents on 19 November 2026. Its monitoring system identified 370 granted patents relevant to plant and animal breeding across 2022 to 2025, while drawing attention to older applications needing special scrutiny. The figures describe a defined monitoring category, not a new law allowing patents on conventional breeding.
Key facts
- The monitoring system counted 73, 89, 109 and 99 granted patents in 2022, 2023, 2024 and 2025 respectively, totalling 370.
- It recorded 279, 293, 245 and 280 agriculturally relevant patent applications in those years.
- The government puts the monitored cases at roughly 0.1% of applications and 0.07% of granted patents across the patent offices considered.
- European Patent Office guidelines exclude plants and animals produced exclusively by essentially biological processes for applications with a filing or priority date after 1 July 2017, with important provisions for older cases.
What the figures actually cover
The Bundestag published its summary on 19 November of government paper 21/9050, dated 13 November. The combined sixth and seventh reports cover 2022-23 and 2024-25. The sixth report had been delayed after the previous parliamentary term ended early. Combining the periods does not itself signal a sudden surge in patenting.
Germany's agricultural authorities monitor selected patents and published applications considered relevant to agricultural plant and animal breeding. They draw on material from the German Patent and Trade Mark Office and the European Patent Office. Patent applications and granted patents are different categories. Moreover, applications are ordinarily published only after about 18 months, so monitoring totals for one calendar year cannot capture every invention originally filed in that year.
Annual monitored grants rose from 73 in 2022 to 109 in 2024, before falling to 99 in 2025. The government's overall comparison with total patent activity finds a small category. Almost all monitored publications came from the European patent system. The report also notes that the livestock part of the monitoring was narrowed towards animal breeding from 2022, restricting comparisons with older reports.
This is why the total of 370 should not be read as 370 newly permitted patents on traditionally bred crops, or as a count of every biotechnology patent. It is a figure for grants caught by a particular monitoring method over four reporting years.
Why pre-2017 applications matter
The European Patent Office's current examination guidelines exclude plants and animals obtained exclusively through essentially biological methods, notably conventional crossing and selection. The exclusion does not automatically cover inventions involving a qualifying technical change to an organism's genetic characteristics. Patent claims must therefore be assessed for their actual subject matter, not simply because they concern a plant or an animal.
The timing rule matters equally. The restriction applies to patent applications with a filing or priority date after 1 July 2017. The EPO says it does not apply retrospectively to patents granted before that date or to pending applications whose relevant dates fall before it. Germany's report says a substantial number of such legacy applications were granted during 2024 and 2025.
The monitoring system labels some publications as requiring particular observation because their claims may relate to conventional breeding. Among granted patents in the plant category, the numbers so classified were 16 in 2022, 22 in 2023, 42 in 2024 and 35 in 2025. Being flagged for observation is not itself a finding that a patent is unlawful or that it has been revoked.
The government attributes much of the temporary increase in such grants to the processing of those older files, not to a reversal of the rule governing new applications. Its report also notes that products of certain technical mutation methods can remain patentable, complicating simple labels such as 'natural' and 'technical'.
The next checkpoint
The report says the EPO aims to complete examination of its remaining older applications by the end of 2026. Subsequent patent decisions and monitoring rounds will show whether the pattern changes after that backlog is addressed.
The parliamentary document does not amend patent rights itself. For farmers, seed companies and breeders, its significance lies in identifying how many rights were monitored, which cases need closer attention and why the legal position depends on the filing date and the exact scope of the claim. Without those distinctions, the raw annual totals give a misleading picture of the law.



